The Surfers evaluate a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. This high-caliber session offers a plethora of practical considerations around accessing approved NASH pharmacotherapies for those most in need.
Jörn Schattenberg, Louise Campbell, Stephen Harrison and Roger Green share “SurfingNASH predictions” of the most important events that will take place between the 5th and 6th International NASH Days.
This final segment with Jeff McIntyre of the Global Liver Institute (GLI) wraps up discussion around what’s happening in NAFLD and NASH for the first quarter of an exciting year. Roger Green invites the panelists to provide the most significant and optimistic thing they will be touching over the next three months followed by the greatest fear each has in the same space.
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking discussion on increasing incidence of Type-2 diabetes among adolescents. The group shares ideas around what’s contributing to this swelling burden and how to dampen its devastating impact.
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking session around bringing hepatology to the public health dinner table. This conversation explores what’s going on in the assessment of package nutrition labeling and fighting for fair regulation around what’s deemed “healthy.”
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking discussion around pricing estimates for imminent drug approvals and the future standard of NITs. This conversation elicits mixed responses ranging from positive excitement to head-scratching concern.
Jörn Schattenberg, Louise Campbell and Roger Green discuss what’s happening thus far for the Fatty Liver field in 2023. The panelists touch on topics ranging from trials with non-invasive endpoints to guidelines, guidances and cross-specialty screening for liver health.
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking impromptu session on what’s happening thus far for the Fatty Liver field in 2023. They discuss emerging stories in science and policy which elicit responses ranging from positive excitement to head-scratching concern.
This conversation From the Vault visits the 2022 Liver Conference coverage of pediatric NASH and NAFLD with guest, Naim Alkhouri.
In this final conversation on pediatric and adolescent Fatty Liver disease, the Surfers conclude thoughts around putting a stop to the momentum amassing dire complications in a vulnerable population.
